Table 1 Baseline characteristics of each group
Control (n = 285) | Group 1A (n = 37) | Group 1B (n = 43) | Group 2A (n = 70) | Group 2B (n = 60) | p-value | Total (n = 495) | |
|---|---|---|---|---|---|---|---|
Non-pachychoroid/Pachychoroid (number) | 177/108 | 11/26 | 16/27 | 38/32 | 39/21 | < 0.001 | 281/214 |
Sex (male/female) | 167/118 | 26/11 | 30/13 | 48/22 | 33/27 | 0.424 | 304/191 |
Age (mean ± SD) | 59.41 ± 13.64 | 57.08 ± 11.35 | 55.74 ± 10.94 | 57.87 ± 11.30 | 59.05 ± 11.33 | 0.385 | 58.66 ± 12.69 |
Prevalence of HTN (number, %) | 144 (50.5) | 17 (45.9) | 21 (48.8) | 36 (51.4) | 29 (48.3) | 0.420 | 247 (49.9) |
Prevalence of dyslipidemia (number, %) | 56 (19.6) | 5 (13.5) | 8 (18.6) | 14 (20.0) | 6 (10.0) | 0.429 | 89 (18.0) |
Prevalence of CVA Hx (number, %) | 42 (14.7) | 6 (2.7) | 2 (4.7) | 6 (8.6) | 5 (8.3) | 0.185 | 61 (12.3) |
Prevalence of kidney disease Hx (number, %) | 19 (6.6) | 4 (10.8) | 6 (14.0) | 8 (11.4) | 4 (6.7) | 0.376 | 41 (8.3) |